In 2023, after a brief hiatus, tuberculosis regained from COVID its status as the world’s deadliest infectious disease—a ...
A South African Medical Research Council (SAMRC) study has revealed that HIV remains one of the leading causes of death in ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
A clinical trial suggests Lenacapavir, a yearly injection, could revolutionise HIV prevention by offering long-term protection, simplifying adherence, and expanding access to at-risk populations.
Company Achieves Key Clinical Milestone with more than 20 Patients Enrolled in Weekly Dosing Cohort of Phase 1 Trial of Decoy20Pharmacodynamic ...
Measles is unlike other childhood viruses. In severe cases, it can cause pneumonia. About 1 in 1,000 patients develops encephalitis.
HIV is not like TB. While TB treatment takes six long months, this is a curable disease. HIV, on the other hand, cannot be ...
A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.
JERUSALEM (AP) — An American biochemist whose research has helped scientists make inroads into treating coronavirus and HIV ...
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results